Kodoth Vivek N, Hodkinson Emily C, Noad Rebecca L, Ashfield Kyle P, Cromie Nicholas A, McEneaney David J, Wilson Carol M, Roberts Michael J D
Cardiology Department, Royal Victoria Hospital, Belfast, Northern Ireland, United Kingdom.
Pacing Clin Electrophysiol. 2012 Dec;35(12):1498-504. doi: 10.1111/pace.12010. Epub 2012 Oct 4.
Insulation defects with externalized conductors have been reported in the St. Jude Riata(®) family of defibrillation leads (St. Jude Medical, Sylmar, CA, USA). The objective of the Northern Ireland Riata(®) lead screening program was to identify insulation defects and externalized conductors by systematic fluoroscopic and electrical assessment in a prospectively defined cohort of patients. We sought to estimate the prevalence, identify risk factors, and determine the natural history of this abnormality.
All patients with a Riata(®) lead under follow-up at the Royal Victoria Hospital were invited for fluoroscopic imaging and implantable cardioverter-defibrillator lead parameter checks. Fluoroscopic images were read independently by two cardiologists and the presence of externalized conductors was classified as positive, negative, or borderline.
One hundred and sixty-five of 212 patients with a Riata lead were evaluated by fluoroscopy and lead parameter measurements. The mean duration after implantation was 3.98+/-1.43 years. After screening 25 (15%) patients were classified as positive, 137 (83%) negative, and three (1.8%) borderline. Time since implantation (P = 0.001), presence of a single coil lead (P = 0.042), and patient age (P = 0.034) were significantly associated with externalized conductors. The observed rate of externalized conductors was 26.9% for 8-French and 4.7% for 7-French leads. No leads that were identified prospectively with externalized conductors had electrical abnormalities. Seven of 25 (28%) patients had a defective lead extracted by the end of this screening period.
A significant proportion (15%) of patients with a Riata lead had an insulation breach 4 years after implantation. High-resolution fluoroscopic imaging in at least two orthogonal views is required to identify this abnormality.
据报道,圣犹达Riata®系列除颤导线(美国加利福尼亚州西尔玛市圣犹达医疗公司)存在绝缘缺陷且导线外露情况。北爱尔兰Riata®导线筛查项目的目的是,通过对一组前瞻性定义的患者进行系统的荧光透视和电气评估,来识别绝缘缺陷和导线外露情况。我们试图估算这种异常情况的患病率、识别风险因素并确定其自然病程。
邀请皇家维多利亚医院所有正在接受Riata®导线随访的患者进行荧光透视成像及植入式心律转复除颤器导线参数检查。两名心脏病专家独立解读荧光透视图像,并将导线外露情况分类为阳性、阴性或临界性。
对212例植入Riata导线的患者中的165例进行了荧光透视及导线参数测量评估。植入后的平均时长为3.98±1.43年。筛查后,25例(15%)患者被分类为阳性,137例(83%)为阴性,3例(1.8%)为临界性。植入后的时间(P = 0.001)、单线圈导线的存在情况(P = 0.042)以及患者年龄(P = 0.034)与导线外露显著相关。8F导线的导线外露观察发生率为26.9%,7F导线为4.7%。前瞻性识别出有导线外露的导线均无电气异常。在本筛查期结束时,25例患者中有7例(28%)的有缺陷导线被取出。
相当一部分(15%)植入Riata导线的患者在植入4年后出现绝缘破损。需要至少在两个正交视图下进行高分辨率荧光透视成像来识别这种异常情况。